# CSB Bancorp, Inc.: financial statements, quarterly

CSBB · OTC · CIK 880417 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/csbb.md) · [Financials](/companies/csbb/financials.md) · [Filings](/companies/csbb/filings.md) · [Insiders](/companies/csbb/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/csbb/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $k | [2,881](/filings/0000950170-23-062898.md) | [3,124 d](/filings/0000950170-24-032295.md) | [3,408](/filings/0000950170-24-057866.md) | [3,578](/filings/0000950170-24-095315.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $k | [850](/filings/0000950170-24-126930.md) | [912 d](/filings/0000950170-25-039227.md) | [693](/filings/0000950170-25-070022.md) | [348](/filings/0000950170-25-106490.md) | [756](/filings/0001193125-25-277449.md) | [526 d](/filings/0001193125-26-108381.md) | [878](/filings/0000880417-26-000004.md) | [903](/filings/0001193125-26-348468.md) | [1,019](/filings/0001193125-25-277449.md) | [400 d](/filings/0001193125-26-108381.md) | [1,093](/filings/0000880417-26-000004.md) | [1,165](/filings/0001193125-26-348468.md) |
| Net income | $k | [3,481](/filings/0000950170-24-126930.md) | [3,697 d](/filings/0000950170-25-039227.md) | [2,933](/filings/0000950170-25-070022.md) | [1,615](/filings/0000950170-25-106490.md) | [3,145](/filings/0001193125-25-277449.md) | [2,319 d](/filings/0001193125-26-108381.md) | [3,616](/filings/0000880417-26-000004.md) | [3,727](/filings/0001193125-26-348468.md) | [4,151](/filings/0001193125-25-277449.md) | [1,869 d](/filings/0001193125-26-108381.md) | [4,444](/filings/0000880417-26-000004.md) | [4,735](/filings/0001193125-26-348468.md) |
| Diluted EPS | $ per share | [1.30](/filings/0000950170-24-126930.md) | not reported | [1.10](/filings/0000950170-25-070022.md) | [0.61](/filings/0000950170-25-106490.md) | [1.18](/filings/0001193125-25-277449.md) | not reported | [1.37](/filings/0000880417-26-000004.md) | [1.41](/filings/0001193125-26-348468.md) | [1.57](/filings/0001193125-25-277449.md) | not reported | [1.69](/filings/0000880417-26-000004.md) | [1.80](/filings/0001193125-26-348468.md) |
| Basic EPS | $ per share | [1.30](/filings/0000950170-24-126930.md) | not reported | [1.10](/filings/0000950170-25-070022.md) | [0.61](/filings/0000950170-25-106490.md) | [1.18](/filings/0001193125-25-277449.md) | not reported | [1.37](/filings/0000880417-26-000004.md) | [1.41](/filings/0001193125-26-348468.md) | [1.57](/filings/0001193125-25-277449.md) | not reported | [1.69](/filings/0000880417-26-000004.md) | [1.80](/filings/0001193125-26-348468.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [1,157](/filings/0000950170-23-062898.md) | [1,179](/filings/0000950170-25-039227.md) | [1,156](/filings/0000950170-24-057866.md) | [1,167](/filings/0000950170-24-095315.md) | [1,209](/filings/0000950170-24-126930.md) | [1,192](/filings/0001193125-26-108381.md) | [1,219](/filings/0000950170-25-070022.md) | [1,238](/filings/0000950170-25-106490.md) | [1,248](/filings/0001193125-25-277449.md) | [1,293](/filings/0001193125-26-348468.md) | [1,266](/filings/0000880417-26-000004.md) | [1,294](/filings/0001193125-26-348468.md) |
| Total liabilities | $m | [1,055](/filings/0000950170-23-062898.md) | [1,071](/filings/0000950170-25-039227.md) | [1,047](/filings/0000950170-24-057866.md) | [1,057](/filings/0000950170-24-095315.md) | [1,094](/filings/0000950170-24-126930.md) | [1,077](/filings/0001193125-26-108381.md) | [1,100](/filings/0000950170-25-070022.md) | [1,116](/filings/0000950170-25-106490.md) | [1,123](/filings/0001193125-25-277449.md) | [1,166](/filings/0001193125-26-348468.md) | [1,136](/filings/0000880417-26-000004.md) | [1,162](/filings/0001193125-26-348468.md) |
| Long-term debt | $m | not reported | [1.8](/filings/0000950170-24-032295.md) | not reported | not reported | not reported | [1.3](/filings/0000950170-25-039227.md) | not reported | not reported | not reported | [0.9](/filings/0001193125-26-108381.md) | not reported | not reported |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [101](/filings/0000950170-24-126930.md) | [108](/filings/0001193125-26-108381.md) | [110](/filings/0000950170-25-106490.md) | [110](/filings/0001193125-25-277449.md) | [115](/filings/0001193125-25-277449.md) | [115](/filings/0001193125-26-348468.md) | [118](/filings/0001193125-26-348468.md) | [122](/filings/0001193125-26-348468.md) | [125](/filings/0001193125-25-277449.md) | [126](/filings/0001193125-26-348468.md) | [129](/filings/0001193125-26-348468.md) | [133](/filings/0001193125-26-348468.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [1,885 d](/filings/0000950170-24-126930.md) | [7,546 d](/filings/0000950170-25-039227.md) | [600](/filings/0000950170-25-070022.md) | [5,389 d](/filings/0000950170-25-106490.md) | [2,945 d](/filings/0001193125-25-277449.md) | [6,731 d](/filings/0001193125-26-108381.md) | [3,053](/filings/0000880417-26-000004.md) | [4,481 d](/filings/0001193125-26-348468.md) | [5,768 d](/filings/0001193125-25-277449.md) | [6,194 d](/filings/0001193125-26-108381.md) | [3,402](/filings/0000880417-26-000004.md) | [6,337 d](/filings/0001193125-26-348468.md) |
| Capital expenditure | $k | [74.0 d](/filings/0000950170-24-126930.md) | [116 d](/filings/0000950170-25-039227.md) | [174](/filings/0000950170-25-070022.md) | [855 d](/filings/0000950170-25-106490.md) | [699 d](/filings/0001193125-25-277449.md) | [232 d](/filings/0001193125-26-108381.md) | [94.0](/filings/0000880417-26-000004.md) | [127 d](/filings/0001193125-26-348468.md) | [128 d](/filings/0001193125-25-277449.md) | [63.0 d](/filings/0001193125-26-108381.md) | [343](/filings/0000880417-26-000004.md) | [159 d](/filings/0001193125-26-348468.md) |
| Dividends paid | $k | [1,016 d](/filings/0000950170-24-126930.md) | [1,014 d](/filings/0000950170-25-039227.md) | [1,039](/filings/0000950170-25-070022.md) | [1,040 d](/filings/0000950170-25-106490.md) | [1,064 d](/filings/0001193125-25-277449.md) | [1,061 d](/filings/0001193125-26-108381.md) | [1,057](/filings/0000880417-26-000004.md) | [1,082 d](/filings/0001193125-26-348468.md) | [1,080 d](/filings/0001193125-25-277449.md) | [1,103 d](/filings/0001193125-26-108381.md) | [1,129](/filings/0000880417-26-000004.md) | [1,130 d](/filings/0001193125-26-348468.md) |
| Share repurchases | $k | [344 d](/filings/0000950170-24-126930.md) | [51.0 d](/filings/0000950170-25-039227.md) | [197](/filings/0000950170-25-070022.md) | [28.0 d](/filings/0000950170-25-106490.md) | [172 d](/filings/0001193125-25-277449.md) | [365 d](/filings/0001193125-26-108381.md) | [328](/filings/0000880417-26-000004.md) | [108 d](/filings/0001193125-26-348468.md) | [290 d](/filings/0001193125-25-277449.md) | [273 d](/filings/0001193125-26-108381.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets, us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

Shares outstanding: 2,627,015 at 2026-08-01, from the cover of the [10-Q filed 2026-08-13](/filings/0001193125-26-348468.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:26 ET. No prices; not investment advice.